Mazdutide

Mazdutide 10mg

Meet Mazdutide: Cut Deeper, Keep the Muscle

Unlock next‑generation fat loss with Mazdutide, a dual GLP‑1 / glucagon receptor agonist designed for aggressive adipose reduction while helping preserve the lean tissue that drives performance.

Where traditional incretin therapies focus mostly on scale weight, Mazdutide is built for smarter body recomposition—targeting fat mass while showing less lean muscle mass loss compared to tirzepatide in emerging data profiles and mechanistic modeling.

Why Mazdutide stands out
• Aggressive fat‑mass reduction
• Less lean muscle mass loss compared to tirzepatide
• Dual‑pathway design (GLP‑1 + glucagon) to support energy expenditure and metabolic flexibility

For performance‑driven body recomposition

If your goal isn’t just “weigh less” but to come out leaner, harder, and more metabolically efficient, Mazdutide represents a cutting‑edge option in the incretin space—engineered to favor fat over muscle when the weight starts coming off.

For research use only. Not for human consumption. No medical claims are made or implied.